Related Experiment Video

Updated: Aug 9, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

Epigenetic therapy with decitabine for myelodysplasia and leukemia

P Wijermans1, M Lübert

  • 1Leyenburg Hospital, Department of Haematology, Leyweg 275, 2545 CH, The Hague, The Netherlands. p.wijermans@hagaziekenhuis.nl

Future Oncology (London, England)
|March 25, 2006
PubMed

Insights

Decitabine, a DNA methylation inhibitor, offers a new therapeutic strategy for cancer. This drug shows promise for treating leukemia and myelodysplastic syndromes by targeting epigenetic changes in tumor cells.

Area of Science:

  • Oncology
  • Epigenetics
  • Pharmacology

Background:

  • Cancer treatment is evolving with new drugs targeting intracellular processes.
  • Epigenetic modifications in tumor cells are emerging as a key therapeutic target.
  • Decitabine (5-aza-2 -deoxycytidine) is an epigenetic drug influencing DNA methylation.

Purpose of the Study:

  • To provide an overview of Decitabine.
  • To discuss the chemistry and pharmacokinetics of Decitabine.
  • To review data supporting Decitabine's efficacy in leukemia and myelodysplastic syndrome.

Main Methods:

  • Literature review of Decitabine's properties.
  • Analysis of clinical data for Decitabine in hematological malignancies.
  • Pharmacokinetic and chemical profile assessment.

Main Results:

  • Decitabine demonstrates significant epigenetic activity by altering DNA methylation.
  • Clinical data suggest Decitabine is a viable therapeutic agent for specific leukemias and myelodysplastic syndromes.
  • The drug's chemistry and pharmacokinetic profile are well-characterized.

Conclusions:

  • Decitabine represents a novel epigenetic therapy for cancer.
  • Its ability to modify DNA methylation supports its use in hematological malignancies.
  • Further research confirms Decitabine's role in treating leukemia and myelodysplastic syndrome.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...